- Home
- XPON vs PBM Comparison
XPON vs PBM Comparison
Compare XPON & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPON
- PBM
- Stock Information
- Founded
- XPON 2016
- PBM 1994
- Country
- XPON United States
- PBM Canada
- Employees
- XPON N/A
- PBM N/A
- Industry
- XPON Electronic Components
- PBM
- Sector
- XPON Technology
- PBM
- Exchange
- XPON Nasdaq
- PBM NYSE
- Market Cap
- XPON 3.2M
- PBM 3.0M
- IPO Year
- XPON 2022
- PBM N/A
- Fundamental
- Price
- XPON $0.83
- PBM $4.91
- Analyst Decision
- XPON
- PBM
- Analyst Count
- XPON 0
- PBM 0
- Target Price
- XPON N/A
- PBM N/A
- AVG Volume (30 Days)
- XPON 54.1K
- PBM 114.1K
- Earning Date
- XPON 08-13-2025
- PBM 07-07-2025
- Dividend Yield
- XPON N/A
- PBM N/A
- EPS Growth
- XPON N/A
- PBM N/A
- EPS
- XPON N/A
- PBM 5.24
- Revenue
- XPON $6,702,411.00
- PBM N/A
- Revenue This Year
- XPON $61.26
- PBM N/A
- Revenue Next Year
- XPON N/A
- PBM N/A
- P/E Ratio
- XPON N/A
- PBM $0.94
- Revenue Growth
- XPON 23.07
- PBM N/A
- 52 Week Low
- XPON $0.60
- PBM $2.93
- 52 Week High
- XPON $120.00
- PBM $701.82
- Technical
- Relative Strength Index (RSI)
- XPON 43.08
- PBM 53.67
- Support Level
- XPON $0.81
- PBM $4.52
- Resistance Level
- XPON $0.97
- PBM $5.23
- Average True Range (ATR)
- XPON 0.08
- PBM 0.54
- MACD
- XPON -0.01
- PBM -0.01
- Stochastic Oscillator
- XPON 18.57
- PBM 49.93
About XPON Expion360 Inc.
Expion360 Inc is focused on the design, assembly, manufacturing, and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles (RV's) and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.
About PBM PSYENCE BIOMEDICAL LTD
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.